The Valley Desk

NCT03400254 · Interventional trial

Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer ("GLACIER")

Overall registry status Withdrawn

Phase 1 · Phase 2

Conditions Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov